In this paper, our data were validated by the observation that cotreatment of PPARγ agonists and the AKT inhibitor triciribine strongly sensitized HCC cells to apoptosis and inhibited their cancer stem cell-like phenotype. This evidence concerns the gene PPARG and hepatocellular carcinoma.